07:00 , Mar 15, 2010 |  BC Week In Review  |  Financial News

Anesiva financial update

Anesiva was delisted from NASDAQ and is now trading on the Pink Sheets. In January, Anesiva said it would cease operations and file for bankruptcy after the company was unable to meet the conditions to...
08:00 , Jan 11, 2010 |  BC Week In Review  |  Company News

Anesiva, Arcion deal

Arcion will not reverse-merge with Anesiva after Anesiva was unable to meet the conditions of the closing. In December, Arcion said the closing of the merger remained conditional on settling outstanding debt, resolving ongoing litigation...
08:00 , Dec 21, 2009 |  BC Week In Review  |  Company News

Anesiva, Lee's Pharmaceuticals Ltd., Powder Pharmaceuticals Inc. deal

Powder and Lee's acquired Anesiva's assets related to Zingo for $2.7 million. The needle-free injection of lidocaine powder is approved by FDA to treat pain associated with blood draws in adults and children, and associated...
08:00 , Dec 14, 2009 |  BC Week In Review  |  Financial News

Anesiva financial update

Anesiva received notice from NASDAQ that it is not in compliance with the minimum $5 million market capitalization requirement for continued listing. The company has until March 2, 2010 to regain compliance. Anesiva Inc. (NASDAQ:ANSV),...
08:00 , Nov 16, 2009 |  BC Week In Review  |  Financial News

Anesiva financial update

Anesiva said NASDAQ accepted the company's plan to regain compliance with listing standards. The company must complete its reverse-merger with Arcion Therapeutics Inc. (Baltimore, Md.) on or before Dec. 31 (see BioCentury, Aug. 10). Anesiva...
07:00 , Oct 5, 2009 |  BC Week In Review  |  Financial News

Anesiva financial update

Anesiva received a letter from NASDAQ indicating the company is not in compliance with the $1 minimum bid price requirement for continued listing. The company has until March 16 to regain compliance. Anesiva Inc. (NASDAQ:ANSV),...
07:00 , Aug 10, 2009 |  BC Week In Review  |  Company News

Anesiva, Arcion deal

Arcion will reverse-merge with Anesiva. Arcion shareholders will own 64% of the combined company, and Anesiva shareholders will own the remaining 36%. The newco will retain Arcion's name and plans to raise at least $20...
07:00 , Aug 3, 2009 |  BC Week In Review  |  Financial News

Anesiva financial update

Anesiva received a letter from NASDAQ saying the company has failed to regain compliance with certain continued listing requirements. The company has requested a hearing to appeal the determination. Anesiva Inc. (NASDAQ:ANSV), South San Francisco,...
07:00 , Mar 23, 2009 |  BioCentury  |  Finance

Ebb & Flow

A proposal written by Washington attorney Leslie Platt that up to $50 billion of TARP money be invested in biotech and other innovation industries was based, in part, on Germany's BioRegio contest in 1996, which...
08:00 , Jan 19, 2009 |  BC Week In Review  |  Clinical News

Zingo regulatory update

FDA approved an sNDA from Anesiva for Zingo to treat pain associated with blood draws in adults. The needle-free injection of lidocaine powder already is approved to treat pain associated with peripheral IV insertions and...